Cover Image
市場調查報告書

美國的產前遺傳檢測市場成長機會·預測:2021年

Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021

出版商 Frost & Sullivan 商品編碼 539623
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的產前遺傳檢測市場成長機會·預測:2021年 Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
出版日期: 2017年07月21日 內容資訊: 英文 90 Pages
簡介

本報告提供美國的產前基因檢測市場形勢的變化相關調查,提供主要4市場區隔 (NIPT,囊狀纖維化症載體基因檢驗,侵入性檢驗,流產檢驗)的詳細收益·市場佔有率分析,產業課題,促進成長要素與抑制因素,競爭的發展,M&A及投資機會等分析。

第1章 執行儀表板

第2章 成長環境:市場概要

  • 調查手法
  • 市場定義:產前遺傳檢測
  • 胎兒染色體非整倍體的盛行率
  • 三位一體的產前檢查
  • 價值鏈
  • 主要法規的發展·未來預測
  • 促進要素·抑制因素

第3章 成長環境:市場預測

  • 市場工程檢測
  • 收益預測的前提條件
  • 收益預測
  • 收益預測的議論
  • 市場佔有率:產前基因檢測的各類型

第4章 成長環境:競爭劇本

  • 產前基因檢測服務供應商形勢
  • 競爭要素·評估
  • 服務供應商形勢:主要組合·各技術

第5章 成長環境:NIPT

  • 市場概要
  • 收益預測的前提條件
  • 收益預測
  • 收益預測的議論
  • 主要打入市場的企業概述
  • NIPT數
  • 市場佔有率:主要競爭企業

第6章 成長環境:囊狀纖維化症 (CF)的載體基因檢驗

  • 市場概要
  • 收益預測的前提條件
  • 收益預測
  • 收益預測的議論
  • 主要打入市場企業的概述

第7章 成長環境:侵入性產前診斷檢驗

  • 市場概要
  • 收益預測的前提條件
  • 收益預測
  • 收益預測的議論
  • 主要打入市場企業的概述

第8章 成長環境:流產檢驗

  • 市場概要
  • 收益預測的前提條件
  • 收益預測
  • 收益預測的議論
  • 主要打入市場企業的概述

第9章 展望方案

  • 從宏觀到微觀
  • 產前基因檢測的趨勢分析
  • 主要的M&A,聯盟的評估
  • 顛覆性的概念,銷售,及組合的多樣化

第10章 成長機會

  • 成長機會1:轉換到目前採用率60-65%的NGS型檢查
  • 成長機會2:以35歲以上的孕婦為目標
  • 成長機會3:針對流通管道行銷,以醫生及遺傳基因個人生活指導員為目標
  • 成長機會4:透過與藥店(CVS,Walgreens),IVD診所和零售夥伴(如亞馬遜)合作強化行銷策略
  • 成長機會5:基於PAMA法規,LDT指南及保險者政策策略的準備
  • 成長機會的矩陣

第11章 結論

第12章 FROST & SULLIVAN

目錄
Product Code: K1C4-55

Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market Growth

Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to undergo pregnancy at an advanced maternal age. The growth in demand has led to a high level of merger and acquisition activity, apart from numerous collaborations, which in turn has bolstered the product portfolio of several companies in the women's healthcare segment. With this accelerated growth, companies are exploring new avenues to market their products, thereby strategically tying up with IVF clinics, physicians, and OBGYNs. New business models like direct to consumer (DTC) are seeing increased uptake due to ease of use and hassle-free processing. Partnerships with Big Data companies will be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity and sensitivity.

Research Scope:

The key objectives of this growth opportunity study are to track the changes in the prenatal genetic testing market landscape in the United States from 2016 to 2021. The study aims to identify growth segments and disruptive companies for investment. Further, it provides an in-depth revenue and market share analysis of 4 key segments, namely, NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers and restraints, competitive developments, mergers and acquisitions, and investment opportunities. It also discusses the impact of Protecting Access to Medicare Act (PAMA) and the LDT guidelines issued by the FDA, identifies transforming business models, and makes strategic recommendations to understand market dynamics. The study also covers key trends and growth opportunities, game-changing companies, disruptive technologies, and strategic recommendations.

Key questions this study will answer include:

  • What are the long-term growth prospects in the market?
  • What are the other areas of growth outside NIPT? What are the opportunities to explore in carrier screening and miscarriage screening?
  • What are some of the innovative companies to action and to follow?
  • How should you price your tests to remain competitive in the market?
  • Who are the established market participants and what are their strategies to remain competent in this market?

Table of Contents

1. EXECUTIVE DASHBOARD

  • Purpose of This Experiential Study
  • 5-step Process to Transformational Growth
  • Scope and Segmentation
  • Segment Overview
  • Market Engineering Measurements
  • Market Snapshot
  • Key Questions Addressed in This Study
  • 5 Major Growth Opportunities
  • Strategic Imperatives for Prenatal Genetic Test Providers

2. GROWTH ENVIRONMENT-MARKET OVERVIEW

  • Methodology
  • Market Definition-Prenatal Genetic Tests
  • Prevalence of Fetal Chromosomal Aneuploidies
  • Prenatal Tests Based on Trimesters
  • Value Chain
  • Major Regulatory Developments and Future Implications
  • Major Regulatory Developments and Future Implications (continued)
  • Major Regulatory Developments and Future Implications (continued)
  • Drivers and Restraints

3. GROWTH ENVIRONMENT-MARKET FORECAST

  • Market Engineering Measurements
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Share by Type of Prenatal Genetic Tests

4. GROWTH ENVIRONMENT-COMPETITIVE PLAYBOOK

  • Prenatal Genetic Test Service Provider Landscape
  • Competitive Factors and Assessment
  • Service Provider Landscape by Key Portfolio and Technology
  • Service Provider Landscape by Key Portfolio and Technology (continued)

5. GROWTH ENVIRONMENT-NIPT

  • Market Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants
  • NIPT Volumes
  • Market Share by Top Competitors

6. GROWTH ENVIRONMENT-CARRIER SCREENING TEST FOR CYSTIC FIBROSIS

  • Market Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

7. GROWTH ENVIRONMENT-INVASIVE PRENATAL DIAGNOSTIC TEST

  • Market Overview
  • Market Overview (continued)
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

8. GROWTH ENVIRONMENT-MISCARRIAGE TEST

  • Market Overview
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Snapshot of Key Market Participants

9. VISIONING SCENARIOS

  • Macro to Micro Visioning
  • Trend Analysis in Prenatal Genetic Testing
  • Trend Analysis in Prenatal Genetic Testing (continued)
  • Key Merger, Acquisition, and Partnership Assessment
  • Disruptive Concepts, Launches, and Portfolio Diversifications
  • Disruptive Concepts, Launches, and Portfolio Diversifications (continued)

10. GROWTH OPPORTUNITIES

  • Growth Opportunity 1-Shift to NGS-based Tests with Present Adoption Rate of 60-65%
  • Growth Opportunity 2-Targeting Pregnant Women above the Age of 35
  • Growth Opportunity 3-Targeting Physicians and Genetic Counselors for Channel Marketing
  • Growth Opportunity 4-Bolstering Marketing Strategies by Providing Tieups with Pharmacies (CVS, Walgreens), IVD Clinics, and Retail Partners like Amazon
  • Growth Opportunity 5-Preparing Strategies Based on PAMA Regulations, LDT Guidelines and Healthcare Payer Policies
  • Growth Opportunity Matrix

11. CONCLUSION

  • Top Predictions
  • Legal Disclaimer

12. APPENDIX

  • Abbreviations and Acronyms Used
  • Abbreviations and Acronyms Used (continued)
  • List of Major Prenatal Genetic Testing Companies
  • Details Regarding the Various Technologies Used by Companies
  • NIPT Process
  • CF Carrier Screen Testing Process
  • Invasive Testing Process
  • Miscarriage Testing Process
Back to Top